An attacin antimicrobial peptide, Hill_BB_C10074, from Hermetia illucens with anti-Pseudomonas aeruginosa activity.
Alphafold
Antibiotics
Antimicrobial peptides
Attacins
Hermetia illucens
Membrane permeability
Pseudomonas aeruginosa
Journal
BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
received:
16
08
2023
accepted:
21
11
2023
medline:
4
12
2023
pubmed:
1
12
2023
entrez:
1
12
2023
Statut:
epublish
Résumé
There is a global need to develop new therapies to treat infectious diseases and tackle the rise in antimicrobial resistance. To date, the larvae of the Black Solider Fly, Hermetia illucens, have the largest repertoire of antimicrobial peptides derived from insects. Antimicrobial peptides are of particular interest in the exploration of alternative antimicrobials due to their potent action and reduced propensity to induce resistance compared with more traditional antibiotics. The predicted attacin from H. illucens, Hill_BB_C10074, was first identified in the transcriptome of H. illucens populations that had been fed a plant-oil based diet. In this study, recombinant Hill_BB_C10074 (500 µg/mL), was found to possess potent antimicrobial activity against the serious Gram-negative pathogen, Pseudomonas aeruginosa. Sequence and structural homology modelling predicted that Hill_BB_C10074 formed a homotrimeric complex that may form pores in the Gram-negative bacterial outer membrane. In vitro experiments defined the antimicrobial action of Hill_BB_C10074 against P. aeruginosa and transmission electron microscopy and electrochemical impedance spectroscopy confirmed the outer membrane disruptive power of Hill_BB_C10074 which was greater than the clinically relevant antibiotic, polymyxin B. Combining predictive tools with in vitro approaches, we have characterised Hill_BB_C10074 as an important insect antimicrobial peptide and promising candidate for the future development of clinical antimicrobials.
Sections du résumé
BACKGROUND
BACKGROUND
There is a global need to develop new therapies to treat infectious diseases and tackle the rise in antimicrobial resistance. To date, the larvae of the Black Solider Fly, Hermetia illucens, have the largest repertoire of antimicrobial peptides derived from insects. Antimicrobial peptides are of particular interest in the exploration of alternative antimicrobials due to their potent action and reduced propensity to induce resistance compared with more traditional antibiotics.
RESULTS
RESULTS
The predicted attacin from H. illucens, Hill_BB_C10074, was first identified in the transcriptome of H. illucens populations that had been fed a plant-oil based diet. In this study, recombinant Hill_BB_C10074 (500 µg/mL), was found to possess potent antimicrobial activity against the serious Gram-negative pathogen, Pseudomonas aeruginosa. Sequence and structural homology modelling predicted that Hill_BB_C10074 formed a homotrimeric complex that may form pores in the Gram-negative bacterial outer membrane. In vitro experiments defined the antimicrobial action of Hill_BB_C10074 against P. aeruginosa and transmission electron microscopy and electrochemical impedance spectroscopy confirmed the outer membrane disruptive power of Hill_BB_C10074 which was greater than the clinically relevant antibiotic, polymyxin B.
CONCLUSIONS
CONCLUSIONS
Combining predictive tools with in vitro approaches, we have characterised Hill_BB_C10074 as an important insect antimicrobial peptide and promising candidate for the future development of clinical antimicrobials.
Identifiants
pubmed: 38036998
doi: 10.1186/s12866-023-03131-1
pii: 10.1186/s12866-023-03131-1
pmc: PMC10690985
doi:
Substances chimiques
attacin antibacterial protein, insect
0
Antimicrobial Peptides
0
Anti-Infective Agents
0
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
378Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M011194/1
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Adv Mater. 2018 Sep;30(39):e1803130
pubmed: 30117203
Antibiotics (Basel). 2021 Apr 08;10(4):
pubmed: 33918040
ACS Biomater Sci Eng. 2023 Jun 12;9(6):3632-3642
pubmed: 37137156
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Biochim Biophys Acta. 2002 Oct 11;1565(2):308-17
pubmed: 12409203
Insects. 2023 May 15;14(5):
pubmed: 37233092
Methods Mol Biol. 2020;2112:29-42
pubmed: 32006276
Sci Rep. 2017 Sep 21;7(1):12124
pubmed: 28935900
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Biochemistry. 2014 Aug 26;53(33):5384-92
pubmed: 25093761
Insect Biochem Mol Biol. 2020 Dec;127:103487
pubmed: 33068728
PLoS One. 2011;6(12):e29113
pubmed: 22216178
Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489
pubmed: 33237286
Nucleic Acids Res. 2016 Jan 4;44(D1):D1094-7
pubmed: 26467475
Langmuir. 2022 Jul 26;38(29):8773-8782
pubmed: 35748045
JAMA. 2020 Apr 21;323(15):1478-1487
pubmed: 32207816
Antibiotics (Basel). 2021 Feb 20;10(2):
pubmed: 33672685
PLoS One. 2017 Jan 5;12(1):e0169582
pubmed: 28056070
ACS Infect Dis. 2021 Sep 10;7(9):2707-2722
pubmed: 34227387
Front Immunol. 2021 Nov 18;12:745160
pubmed: 34867970
Protein J. 2019 Jun;38(3):200-216
pubmed: 31119599
Prep Biochem Biotechnol. 2019;49(3):279-285
pubmed: 30767702
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Int J Mol Sci. 2021 Oct 22;22(21):
pubmed: 34768832
Curr Pharm Des. 2022;28(35):2856-2866
pubmed: 35980058
J Bacteriol. 2013 Jul;195(13):2971-81
pubmed: 23625841
Dev Comp Immunol. 2015 Sep;52(1):98-106
pubmed: 25956195
Front Nutr. 2022 Jan 18;8:812011
pubmed: 35118109
Sci Rep. 2020 Oct 9;10(1):16875
pubmed: 33037295
Dev Comp Immunol. 2018 Jan;78:141-148
pubmed: 28966127
Front Microbiol. 2020 Jun 05;11:1057
pubmed: 32582062
Antimicrob Resist Infect Control. 2022 Mar 7;11(1):45
pubmed: 35255988
Transl Anim Sci. 2022 Jun 22;6(3):txac084
pubmed: 35854966
J Fungi (Basel). 2021 May 31;7(6):
pubmed: 34072802
J Food Biochem. 2021 Apr;45(4):e13598
pubmed: 33595118
Antimicrob Agents Chemother. 2014;58(4):1956-62
pubmed: 24419348
Drugs. 2021 Dec;81(18):2117-2131
pubmed: 34743315
Int J Mol Sci. 2023 Mar 17;24(6):
pubmed: 36982826
Cell Mol Life Sci. 2021 May;78(9):4259-4282
pubmed: 33595669
J Biol Chem. 2020 Jul 24;295(30):10340-10367
pubmed: 32499369
Nature. 2003 Nov 6;426(6962):33-8
pubmed: 14603309
Front Cell Infect Microbiol. 2021 Jun 14;11:668632
pubmed: 34195099
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28167546